These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6481425)

  • 21. Phase-I trial of intracarotid BCNU and cisplatin in patients with malignant intracerebral tumors.
    Feun LG; Wallace S; Yung WK; Lee YY; Leavens ME; Moser R; Savaraj N; Burgess MA; Plager C; Benjamin RS
    Cancer Drug Deliv; 1984; 1(3):239-45. PubMed ID: 6544123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
    Prados MD; Larson DA; Lamborn K; McDermott MW; Sneed PK; Wara WM; Chang SM; Mack EE; Krouwer HG; Chandler KL; Warnick RE; Davis RL; Rabbitt JE; Malec M; Levin VA; Gutin PH; Phillips TL; Wilson CB
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):57-63. PubMed ID: 9422558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.
    Greenberg HS; Ensminger WD; Chandler WF; Layton PB; Junck L; Knake J; Vine AK
    J Neurosurg; 1984 Sep; 61(3):423-9. PubMed ID: 6747681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
    Van Dyk JJ; Falkson G
    Med Pediatr Oncol; 1975; 1(2):107-11. PubMed ID: 1228411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas.
    Jakacki RI; Jamison C; Mathews VP; Heilman DK; Dropcho E; Cornetta K; Macdonald DR; Williams DA
    Med Pediatr Oncol; 1998 Dec; 31(6):483-90. PubMed ID: 9835900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological deficit after carotid infusion of cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) for malignant glioma: an analysis of risk factors.
    Kapp JP; Sanford RA
    Neurosurgery; 1986 Nov; 19(5):779-83. PubMed ID: 3785625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation.
    Bobo H; Kapp JP; Vance R
    J Neurooncol; 1992 Jul; 13(3):291-9. PubMed ID: 1517805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between BCNU and procarbazine chemotherapy for treatment of gliomas.
    Newton HB; Bromberg J; Junck L; Page MA; Greenberg HS
    J Neurooncol; 1993 Mar; 15(3):257-63. PubMed ID: 8360711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study--intra-arterial BCNU therapy for metastatic brain tumors.
    Madajewicz S; West CR; Park HC; Ghoorah J; Avellanosa AM; Takita H; Karakousis C; Vincent R; Caracandas J; Jennings E
    Cancer; 1981 Feb; 47(4):653-7. PubMed ID: 6261914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ischemic optic neuropathy secondary to intracarotid infusion of BCNU.
    Pickrell L; Purvin V
    J Clin Neuroophthalmol; 1987 Jun; 7(2):87-92. PubMed ID: 2956289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orbital angiographic changes after intracarotid BCNU chemotherapy.
    Gebarski SS; Greenberg HS; Gabrielsen TO; Vine AK
    AJNR Am J Neuroradiol; 1984; 5(1):55-8. PubMed ID: 6421125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors.
    Levin VA; Hoffman WF; Pischer TL; Seager ML; Boldrey EB; Wilson CB
    Cancer Treat Rep; 1978 Dec; 62(12):2071-6. PubMed ID: 221113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.
    Levin VA; Crafts DC; Wilson CB; Schultz MJ; Boldrey EB; Enot KJ; Pischer TL; Seager M; Elashoff RM
    Cancer Treat Rep; 1976 Mar; 60(3):243-9. PubMed ID: 177210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors.
    Levin VA; Edwards MS; Wright DC; Seager ML; Schimberg TP; Townsend JJ; Wilson CB
    Cancer Treat Rep; 1980; 64(2-3):237-44. PubMed ID: 7407756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report.
    Safdari H; Mompeon B; Dubois JB; Gros C
    Surg Neurol; 1985 Nov; 24(5):490-7. PubMed ID: 4049223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
    Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
    Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metoclopramide as a sensitizer of 1,3-bis(2-chloroethyl)-1-nitrosourea treatment of brain tumors in the rat.
    Salford LG; Pero RW; Aas AT; Brun A
    Anticancer Drugs; 1992 Jun; 3(3):267-72. PubMed ID: 1525408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles.
    Han L; Ren Y; Long L; Zhong Y; Shen C; Pu P; Yuan X; Kang C
    Oncol Rep; 2012 Jan; 27(1):121-8. PubMed ID: 21922149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors.
    Stewart DJ; Grahovac Z; Hugenholtz H; DaSilva V; Richard MT; Benoit B; Belanger G; Russell N
    J Neurooncol; 1993 Jul; 17(1):71-9. PubMed ID: 8120574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced systemic drug exposure by combining intra-arterial chemotherapy with hemoperfusion of regional venous drainage.
    Oldfield EH; Dedrick RL; Yeager RL; Clark WC; DeVroom HL; Chatterji DC; Doppman JL
    J Neurosurg; 1985 Nov; 63(5):726-32. PubMed ID: 4056874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.